Sonnet BioTherapeutics Holdings (SONN) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

SONN is expected to report earnings to rise 3,061.54% to -411 cents per share on November 29

Sonnet BioTherapeutics Holdings SONN Stock Earnings Reports

Q3'23

Est.

$-4.11

Q2'23

Beat

by $0.16

Q1'23

Missed

by $6.99

Q4'22

Beat

by $0.33

Q3'22

Missed

by $35.23

The last earnings report on August 14 showed earnings per share of -12 cents, beating the estimate of -28 cents. With 119.67K shares outstanding, the current market capitalization sits at 4.63M.

View a ticker or compare two or three

Compare

SONN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SONN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in the development of biologic drugs with enhanced single or bispecific mechanisms

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

100 Overlook Center

Phone

+1 609 375-2227

Employees

Web

https://www.sonnetbio.com